MCID: PLC007
MIFTS: 47

Placental Abruption malady

Categories: Fetal diseases

Aliases & Classifications for Placental Abruption

Aliases & Descriptions for Placental Abruption:

Name: Placental Abruption 12 14
Abruptio Placentae 12 52 69
Abortion, Threatened 42
Abruptio Placenta 12

Classifications:



External Ids:

Disease Ontology 12 DOID:9667
ICD10 33 O20.0
ICD9CM 35 640.0 640.03
MeSH 42 D000033
NCIt 47 C112857
UMLS 69 C0000821

Summaries for Placental Abruption

Disease Ontology : 12 A placenta disease that is characterized by separation of the placental lining from the uterus of the mother.

MalaCards based summary : Placental Abruption, also known as abruptio placentae, is related to influenza and kidney cortex necrosis. An important gene associated with Placental Abruption is MTHFR (Methylenetetrahydrofolate Reductase), and among its related pathways/superpathways are Response to elevated platelet cytosolic Ca2+ and Collagen chain trimerization. The drugs Methyldopa and Progesterone have been mentioned in the context of this disorder. Affiliated tissues include placenta, uterus and heart, and related phenotypes are cardiovascular system and embryo

Wikipedia : 71 Placental abruption, also known as abruptio placentae, is a complication of pregnancy, wherein the... more...

Related Diseases for Placental Abruption

Diseases related to Placental Abruption via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 166)
id Related Disease Score Top Affiliating Genes
1 influenza 29.8 F2 SERPINC1
2 kidney cortex necrosis 11.0
3 multiple familial trichoepithelioma 10.3 F5 MTHFR
4 absence of innominate vein 10.3 F5 MTHFR
5 aminoaciduria 10.3 F5 MTHFR
6 congenital insensitivity to pain with severe intellectual disability 10.3 F2 F5
7 scn8a-related epilepsy with encephalopathy 10.3 F2 MTHFR
8 med13l syndrome 10.3 APOH F5
9 porphyria 10.3 F2 MTHFR
10 achard thiers syndrome 10.3 APOH F5
11 oxyphilic adenoma 10.3 F2 F5
12 stroke, ischemic 10.3 F2 F5
13 landau-kleffner syndrome 10.2 APOH F2
14 stt3a-cdg and stt3b-cdg 10.2 F5 SERPINC1
15 fletcher factor deficiency 10.2 F2 F5
16 prostatitis 10.2 APOH F2
17 photosensitive epilepsy 10.2 F2 F5 MTHFR
18 miller-dieker lissencephaly syndrome 10.2 F2 SERPINC1
19 freiberg's disease 10.2 F2 SERPINC1
20 houlston ironton temple syndrome 10.2 F2 F5 MTHFR
21 villous adenoma 10.2 F2 F5 MTHFR
22 childhood type dermatomyositis 10.2 F2 F5 MTHFR
23 lung cancer 10.2 APOH F5 MTHFR
24 cervix small cell carcinoma 10.2 F2 F5 MTHFR
25 central congenital hypothyroidism 10.2 APOH F5 MTHFR
26 hereditary acrokeratotic poikiloderma, weary type 10.2 MTHFD1 MTHFR
27 hendra virus infection 10.2 APOH F2 F5
28 chorioretinal scar 10.2 F2 SERPINC1
29 myelocystocele 10.2 MTHFD1 MTHFR
30 posterior meningocele 10.2 MTHFD1 MTHFR
31 mixed hepatoblastoma 10.2 F2 SERPINC1
32 glutathionuria 10.2 APOH F2 MTHFR
33 pericardial and diaphragmatic defect 10.2 MTHFD1 MTHFR
34 hereditary thrombocytopenia with normal platelets 10.2 MTHFD1 MTHFR
35 peanut allergy 10.2 F2 SERPINC1
36 thoracolumbosacral spina bifida aperta 10.2 MTHFD1 MTHFR
37 lumbosacral spina bifida aperta 10.2 MTHFD1 MTHFR
38 cervical spina bifida aperta 10.2 MTHFD1 MTHFR
39 mycophenolate mofetil embryopathy 10.2 MTHFD1 MTHFR
40 complication in hemodialysis 10.2 MTHFD1 MTHFR
41 dmd-related dilated cardiomyopathy 10.2 F2 SERPINC1
42 intermediate maple syrup urine disease 10.2 MTHFD1 MTHFR
43 46,xx disorder of sex development-anorectal anomalies syndrome 10.2 MTHFD1 MTHFR
44 glycogen storage disease due to liver phosphorylase kinase deficiency 10.1 MTHFD1 MTHFR
45 midline cystocele 10.1 F2 SERPINC1
46 deafness, autosomal recessive 45 10.1 MTHFD1 MTHFR
47 eclampsia 10.1
48 schwannoma of jugular foramen 10.1 F2 SERPINC1
49 myotonic dystrophy 10.1 F2 F5
50 myosclerosis, congenital 10.1 F5 MTHFR SERPINC1

Graphical network of the top 20 diseases related to Placental Abruption:



Diseases related to Placental Abruption

Symptoms & Phenotypes for Placental Abruption

MGI Mouse Phenotypes related to Placental Abruption:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.03 ENG F2 F5 FLT1 MTHFD1 PGF
2 embryo MP:0005380 10.01 ENG F2 F5 FLT1 MTHFD1 PGF
3 growth/size/body region MP:0005378 9.97 ENG F2 F5 FLT1 MTHFD1 MTHFR
4 homeostasis/metabolism MP:0005376 9.96 PGF SERPINC1 THBD APOH ENG F2
5 hematopoietic system MP:0005397 9.87 EBAG9 ENG F2 FLT1 MTHFD1 SERPINC1
6 integument MP:0010771 9.63 F2 F5 MTHFR PGF THBD ENG
7 mortality/aging MP:0010768 9.61 APOH ENG F2 F5 FLT1 MTHFD1
8 nervous system MP:0003631 9.23 ENG F2 F5 FLT1 MTHFD1 MTHFR

Drugs & Therapeutics for Placental Abruption

Drugs for Placental Abruption (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 125)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Methyldopa Approved Phase 4 555-30-6 38853
2
Progesterone Approved, Vet_approved Phase 4,Phase 3 57-83-0 5994
3
Oxytocin Approved, Vet_approved Phase 4,Phase 3,Phase 1 50-56-6 439302 53477758
4
Pyrimethamine Approved, Vet_approved Phase 4 58-14-0 4993
5
Sulfadoxine Approved Phase 4 2447-57-6 17134
6
Clindamycin Approved, Vet_approved Phase 4 18323-44-9 29029
7
Magnesium Sulfate Approved, Vet_approved Phase 4,Phase 3 7487-88-9 24083
8
Lumefantrine Approved Phase 4 82186-77-4 6437380
9
leucovorin Approved, Nutraceutical Phase 4,Phase 3 58-05-9 54575, 6560146 143
10
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3 59-30-3 6037
11 Analgesics Phase 4,Phase 3,Phase 2
12 Tocolytic Agents Phase 4,Phase 3,Phase 2
13 Trace Elements Phase 4,Phase 3
14 Hormones Phase 4,Phase 3
15 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2
16 Vitamin B Complex Phase 4,Phase 3
17 Vitamins Phase 4,Phase 3
18 Antihypertensive Agents Phase 4
19 Micronutrients Phase 4,Phase 3
20 Calcium, Dietary Phase 4,Phase 3,Phase 2
21 Progestins Phase 4,Phase 3
22 calcium channel blockers Phase 4,Phase 3
23 Folic Acid Antagonists Phase 4
24 Clindamycin palmitate Phase 4
25 Clindamycin phosphate Phase 4
26 Thioctic Acid Phase 4
27 Hormone Antagonists Phase 4,Phase 3
28 Anesthetics Phase 4,Phase 3,Phase 1
29 Oxytocics Phase 4,Phase 3,Phase 2,Phase 1
30 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3
31 Anti-Arrhythmia Agents Phase 4,Phase 3
32 Anti-Bacterial Agents Phase 4
33 Anti-Infective Agents Phase 4,Phase 3
34 Fanasil, pyrimethamine drug combination Phase 4
35 Anticonvulsants Phase 4,Phase 3
36 Protective Agents Phase 4,Phase 3
37 Antimalarials Phase 4
38 Renal Agents Phase 4
39 Artemether-lumefantrine combination Phase 4
40 Antioxidants Phase 4,Phase 3
41 Antiparasitic Agents Phase 4
42 Central Nervous System Depressants Phase 4,Phase 3,Phase 1
43 Antiprotozoal Agents Phase 4
44 Folate Nutraceutical Phase 4,Phase 3
45 Vitamin B9 Nutraceutical Phase 4,Phase 3
46 Alpha-lipoic Acid Nutraceutical Phase 4
47
Aspirin Approved, Vet_approved Phase 3,Phase 2 50-78-2 2244
48
Heparin Approved, Investigational Phase 3 9005-49-6 772 46507594
49
Tranexamic Acid Approved Phase 3 1197-18-8 5526
50
Hydroxocobalamin Approved Phase 3 13422-51-0 11953898 5460373 44475014

Interventional clinical trials:

(show top 50) (show all 73)
id Name Status NCT ID Phase
1 Anti-Hypertensive Treatment In Stable Pregnant Women With Severe Pre-Eclampsia (Metildopape) Unknown status NCT01361425 Phase 4
2 Vaginal Administration of ALA vs Progesterone for the Subchorionic Hematoma Treatment Completed NCT02601898 Phase 4
3 Intermittent Preventive Treatment Versus Scheduled Screening and Treatment of Malaria in Pregnancy Completed NCT01084213 Phase 4
4 Prevention of Very Preterm Delivery by Testing for and Treatment of Bacterial Vaginosis Completed NCT00642980 Phase 4
5 Induction of Labor With a Foley Balloon Catheter: Inflation With 30ml Compared to 60ml Completed NCT00451308 Phase 4
6 Foley Bulb With Low Dose Pitocin Versus Foley Bulb With a Standard Incremental Infusion Protocol for the Induction of Labor Completed NCT02150954 Phase 4
7 Cerclage vs Cervical Pessary in Women With Cervical Incompetence Recruiting NCT02405455 Phase 4
8 Different Schemes of Magnesium Sulfate for Preeclampsia Terminated NCT02396030 Phase 4
9 Folic Acid Dosage and Malformations Reduction Unknown status NCT01244347 Phase 3
10 Low Dose Aspirin for the Prevention of Preeclampsia Unknown status NCT01890005 Phase 3
11 Prevention of Maternal and Perinatal Complications by Enoxaparin in Women With Previous Severe Preeclampsia Completed NCT00986765 Phase 3
12 Low Molecular Weight Heparin and/or Aspirin in Prevention of Habitual Abortion Completed NCT00959621 Phase 3
13 Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial) Completed NCT00014989 Phase 3
14 Intraumbilical Vein Injection of Oxytocin in Routine Practice for Active Management of the Third Stage of Labor Completed NCT01094028 Phase 3
15 Syringe or Continuous Amnioreduction for Symptomatic Polyhydramnios. A Prospective Randomized Study. Completed NCT00236340 Phase 3
16 Can we Use Intravenous Injection of Tranexamic Acid in Routine Practice With Active Management of the Third Stage of Labor? Completed NCT01338454 Phase 3
17 TIPPS: Thrombophilia in Pregnancy Prophylaxis Study Completed NCT00967382 Phase 3
18 Controlled Cord Traction During Third Stage of Labor Completed NCT00781066 Phase 3
19 Effectiveness of Dalteparin Therapy as Intervention in Recurrent Pregnancy Loss Completed NCT00400387 Phase 3
20 RCT of Antioxidant Therapy to Prevent Preeclampsia in Brazil Completed NCT00097110 Phase 3
21 High Dose Folic Acid Supplementation Throughout Pregnancy for Preeclampsia Prevention Completed NCT01355159 Phase 3
22 Trial of Progesterone in Twins and Triplets to Prevent Preterm Birth (STTARS) Completed NCT00099164 Phase 3
23 Randomized Double-blind Controlled Trial of Use of Dydrogesterone in Threatened Miscarriage Recruiting NCT02128685 Phase 3
24 Low Dose Aspirin in the Prevention of Preeclampsia in China Recruiting NCT02797249 Phase 3
25 A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV) Recruiting NCT01376778 Phase 3
26 A Randomized Trial of Docosahexaenoic Acid Supplementation During Pregnancy to Prevent Deep Placentation Disorders Recruiting NCT02336243 Phase 3
27 Progesterone in Threatened Abortion Not yet recruiting NCT02950935 Phase 3
28 Utility of Tocolytic Therapy for Maintenance Tocolysis in the Management of Threatened Preterm Delivery Withdrawn NCT01796522 Phase 3
29 Indomethacin Versus Placebo in Women With Preterm Premature Rupture of Membranes (PPROM) Unknown status NCT00466128 Phase 2
30 Impact of the NO-donor Pentaerythrithyltetrantrate on Perinatal Outcome in High-risk Pregnancies Completed NCT01355822 Phase 1, Phase 2
31 Vaginal Misoprostol In Management Of First Trimester Missed Abortion. Not yet recruiting NCT03148314 Phase 2
32 Sildenafil Citrate for the Management of Asymmetrical Intrauterine Growth Restriction Not yet recruiting NCT02678221 Phase 2
33 Usefulness of Extracorporeal Removal of sFLT-1 in Women With Very Early Severe Preeclampsia Terminated NCT02286284 Phase 2
34 A Comparison of B Type Natriuretic Peptide Levels and Hemodynamics Using the Nexfin Device in Healthy Pregnant and Preeclamptic Women - A Pilot Study Unknown status NCT02527018 Phase 1
35 Prophylactic Use of Intraumbilical Vein Oxytocin Injection in The Management of Third Stage of Labor Recruiting NCT02680938 Phase 1
36 Spinal Analgesia Versus No Analgesia: Study for External Cephalic Version Terminated NCT00119184 Phase 1
37 Severe Pregnancy Complications Are Associated With Elevated Factor VIII Plasma Activity Unknown status NCT00573118
38 Relation Between Subclinical Hypothyroidism and Outcome of Pregnancy Unknown status NCT01335802
39 Pre-Eclampsia Prediction By Doppler Screening Of Uterine Arteries And Angiogenic Factors In Second Trimester Of Pregnancy Unknown status NCT00725660
40 Comparison of Efficiency Between Practicing of Knee Chest Position and External Cephalic Version in Cases of Breech Presentation. Unknown status NCT02167841
41 The Prognosis of Early Pregnancy With Post Coital Bleeding Unknown status NCT02363569
42 İs There a Relationship Between Severity of Preeclampsia and Maternal Heavy Metal Levels? Unknown status NCT01906567
43 Optimizing Technology-Delivered Interventions for Smoking in Pregnancy: The Mommy Check-Up Study. Unknown status NCT02340624
44 The SMART-ORACLE Study Unknown status NCT01932671
45 Pregnancy Outcome in Woman With Threatened Abortion Completed NCT02686112
46 Corpus Luteum and Uterine Artery Doppler With Serum P and CA125 in Threatened Abortion Completed NCT02420769
47 Pelvic Examination in Pregnancy Completed NCT01570413
48 Duphaston in Cycle Regularization: A Post-marketing, Prospective, Multicenter, Observational Study Completed NCT01525563
49 Prevention of Post-partum Haemorrhage Completed NCT01044082
50 Comparing Blood Loss During Caesarean Section Between Manual Separation of Placenta & Conservative Management Completed NCT02480556

Search NIH Clinical Center for Placental Abruption

Cochrane evidence based reviews: abortion, threatened

Genetic Tests for Placental Abruption

Anatomical Context for Placental Abruption

MalaCards organs/tissues related to Placental Abruption:

39
Placenta, Uterus, Heart, Testes, Endothelial, Brain, Retina

Publications for Placental Abruption

Articles related to Placental Abruption:

(show top 50) (show all 339)
id Title Authors Year
1
A Rare Cause of Placental Abruption: Uterine Torsion. ( 26894131 )
2016
2
Circulating Levels of Pregnancy-Associated, Placenta-Specific microRNAs in Pregnant Women With Placental Abruption. ( 27297699 )
2016
3
Trauma in pregnant women: assessing detection of post-traumatic placental abruption on contrast-enhanced CT versus ultrasound. ( 27853848 )
2016
4
ASSOCIATION BETWEEN PLACENTAL ABRUPTION AND CAESAREAN SECTION AMONG PATIENTS AT KHYBER TEACHING HOSPITAL PESHAWAR. ( 27323587 )
2016
5
Developmental outcomes in children following placental abruption: novel methods to disentangle causes and mediators. ( 27132247 )
2016
6
Placental abruption possibly due to parvovirus B19 infection. ( 27547655 )
2016
7
Randomized, Double-Blinded Trial of Magnesium Sulfate Tocolysis versus Intravenous Normal Saline for Preterm Nonsevere Placental Abruption. ( 26871905 )
2016
8
Use of uterine artery embolization toA prevent peripartum hemorrhage of placental abruption with fetal demise & severe DIC. ( 27589544 )
2016
9
Placental genetic variations in circadian clock-related genes increase the risk of placental abruption. ( 27186326 )
2016
10
Does apoptotic activity have a role in the development of the placental abruption? ( 27893299 )
2016
11
Maternal Early Pregnancy Serum Metabolomics Profile and Abnormal Vaginal Bleeding as Predictors of Placental Abruption: A Prospective Study. ( 27300725 )
2016
12
Neurodevelopmental outcomes in children in relation to placental abruption. ( 27102365 )
2016
13
The Necessity of Awareness of Early Symptoms of Placental Abruption Among Pregnant Japanese Women. ( 27540442 )
2016
14
Pre-delivery fibrinogen predicts adverse maternal or neonatal outcomes in patients with placental abruption. ( 27075198 )
2016
15
Placental Abruption Revealed by Hemoperitoneum: A Case Report. ( 27994944 )
2016
16
Diagnosis of placental abruption: a legal issue for physicians. ( 26866304 )
2016
17
Ambient PM2.5 Aluminum and Elemental Carbon and Placental Abruption Morbidity. ( 28002353 )
2016
18
Poster 46 Multiple Amputations Including Bilateral Transtibial Amputations in a 29-Year-Old Female After Suffering Placental Abruption, GBS Septicemia and DIC: AA Case Report. ( 27672813 )
2016
19
The role of mean platelet volume and platelet distribution width in the prediction of placental abruption. ( 27184035 )
2016
20
Air Pollutant Exposure within a Few Days of Delivery and Placental Abruption in Japan. ( 27922526 )
2016
21
Fetal cerebral and umbilical Doppler in pregnancies complicated by late-onset placental abruption. ( 27484964 )
2016
22
Coagulopathy and placental abruption: changing management with ROTEM-guided fibrinogen concentrate therapy. ( 25840856 )
2015
23
Severe placental abruption: clinical definition and associations with maternal complications. ( 26393335 )
2015
24
Treatment of pregnant patient with disseminated intravascular coagulation (DIC) due to placental abruption--a case report. ( 26524829 )
2015
25
Change in paternity, risk of placental abruption and confounding by birth interval: a population-based prospective cohort study in Norway, 1967-2009. ( 25670732 )
2015
26
Association of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism with preterm delivery and placental abruption: a systematic review and meta-analysis. ( 26439908 )
2015
27
Re: Prenatal vitamin C and E supplementation in smokers is associated with reduced placental abruption and preterm birth: a secondary analysis. ( 25892472 )
2015
28
Factor V Leiden, Prothrombin and MTHFR Mutation in Patients with Preeclamsia, Intrauterine Growth Restriction and Placental Abruption. ( 27275292 )
2015
29
Cesarean Delivery for a Life-threatening Preterm Placental Abruption. ( 27057388 )
2015
30
Placental abruption and long-term maternal cardiovascular disease mortality: a population-based registry study in Norway and Sweden. ( 26177801 )
2015
31
Placental Abruption and Subsequent Risk of Pre-eclampsia: A Population-Based Case-Control Study. ( 25761509 )
2015
32
Incidence and recurrence rate of placental abruption: a longitudinal linked national cohort study in the Netherlands. ( 26071916 )
2015
33
An international contrast of rates of placental abruption: an age-period-cohort analysis. ( 26018653 )
2015
34
[186-POS]: Role of coagulation factors in placental abruption in the Chinese population. ( 25787537 )
2015
35
Spontaneous Splenic Rupture Mimicking Placental Abruption in the Second Trimester: a Case Report and Review of the Literature. ( 27132334 )
2015
36
Rapid-Sequence Intubation in the Left-Lateral Tilt Position in a Pregnant Woman with Premature Placental Abruption Utilizing a Videolaryngoscope. ( 26199794 )
2015
37
Placental abruption: Are we going to lose them both? ( 25871760 )
2015
38
[130-POS]: Placental abruption and long-term maternal cardiovascular disease mortality: A population-based registry study in Norway and Sweden. ( 25787479 )
2015
39
Nonlinear analysis of fetal heart rate dynamics in fetuses compromised by asymptomatic partial placental abruption. ( 26602608 )
2015
40
Thymic pathology in placental abruption: an autopsy study of third trimester stillborns in a predominantly African-American population. ( 26586552 )
2015
41
Coagulopathy and placental abruption: changing management with ROTEM-guided fibrinogen concentrate therapy. ( 25659517 )
2015
42
Abnormal patterns of blood flow through the uterine arteries: Is it a clue for placental abruption in clinically suspected cases? ( 25774964 )
2015
43
[231-POS]: Recurrent abruption in hypertensive pregnancy; a case report and historical control study for the mode of delivery after fetal death by placental abruption. ( 25787581 )
2015
44
Placental mitochondrial DNA content and placental abruption: a pilot study. ( 26377917 )
2015
45
Circadian clock-related genetic risk scores and risk of placental abruption. ( 26515929 )
2015
46
Placental telomere length and risk of placental abruption. ( 26611732 )
2015
47
Predictors of perinatal mortality associated with placenta previa and placental abruption: an experience from a low income country. ( 25002975 )
2014
48
Vaginal delivery after placental abruption and intrauterine fetal death, including failed cases. ( 24745855 )
2014
49
Clinical significance of adverse outcomes of placental abruption developing at home. ( 25383961 )
2014
50
The risk of placental abruption and placenta previa in pregnant women with chronic hepatitis B viral infection: a systematic review and meta-analysis. ( 24934739 )
2014

Variations for Placental Abruption

Expression for Placental Abruption

Search GEO for disease gene expression data for Placental Abruption.

Pathways for Placental Abruption

GO Terms for Placental Abruption

Cellular components related to Placental Abruption according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.23 APOH ENG F2 F5 FLT1 PGF

Biological processes related to Placental Abruption according to GeneCards Suite gene sharing:

(show all 16)
id Name GO ID Score Top Affiliating Genes
1 angiogenesis GO:0001525 9.73 ENG FLT1 PGF
2 cellular protein metabolic process GO:0044267 9.72 F2 F5 SERPINC1
3 positive regulation of angiogenesis GO:0045766 9.63 ENG FLT1 PGF
4 blood coagulation GO:0007596 9.56 F2 F5 SERPINC1 THBD
5 sprouting angiogenesis GO:0002040 9.54 ENG PGF
6 positive regulation of collagen biosynthetic process GO:0032967 9.52 ENG F2
7 folic acid metabolic process GO:0046655 9.51 MTHFD1 MTHFR
8 blood coagulation, intrinsic pathway GO:0007597 9.49 APOH F2
9 positive regulation of blood coagulation GO:0030194 9.48 APOH F2
10 negative regulation of blood coagulation GO:0030195 9.43 APOH THBD
11 tetrahydrofolate interconversion GO:0035999 9.4 MTHFD1 MTHFR
12 negative regulation of platelet activation GO:0010544 9.37 F2 THBD
13 regulation of blood coagulation GO:0030193 9.33 APOH F2 SERPINC1
14 methionine metabolic process GO:0006555 9.32 MTHFD1 MTHFR
15 negative regulation of fibrinolysis GO:0051918 9.13 APOH F2 THBD
16 hemostasis GO:0007599 8.92 F2 F5 SERPINC1 THBD

Molecular functions related to Placental Abruption according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 heparin binding GO:0008201 8.92 APOH F2 PGF SERPINC1

Sources for Placental Abruption

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....